These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 31419461)
41. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497 [TBL] [Abstract][Full Text] [Related]
42. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery. Song J; Fan X; Shen Q Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353 [TBL] [Abstract][Full Text] [Related]
43. Dermal targeting of tacrolimus using colloidal carrier systems. Goebel AS; Neubert RH; Wohlrab J Int J Pharm; 2011 Feb; 404(1-2):159-68. PubMed ID: 21094231 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies. Puglia C; Damiani E; Offerta A; Rizza L; Tirendi GG; Tarico MS; Curreri S; Bonina F; Perrotta RE Eur J Pharm Sci; 2014 Jan; 51():211-7. PubMed ID: 24157543 [TBL] [Abstract][Full Text] [Related]
45. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies. Kumar D; Ali J; Baboota S Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633 [TBL] [Abstract][Full Text] [Related]
46. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration. Okonogi S; Riangjanapatee P Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097 [TBL] [Abstract][Full Text] [Related]
47. Nanostructuring lipid carriers using Ridolfia segetum (L.) Moris essential oil. Miranda M; Cruz MT; Vitorino C; Cabral C Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109804. PubMed ID: 31349527 [TBL] [Abstract][Full Text] [Related]
48. Development of microemulsions of suitable viscosity for cyclosporine skin delivery. Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819 [TBL] [Abstract][Full Text] [Related]
49. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis. Kaur N; Sharma K; Bedi N Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899 [TBL] [Abstract][Full Text] [Related]
50. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Abdel-Mottaleb MM; Neumann D; Lamprecht A Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002 [TBL] [Abstract][Full Text] [Related]
51. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Nnamani PO; Hansen S; Windbergs M; Lehr CM Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810 [TBL] [Abstract][Full Text] [Related]
52. A Novel Approach for the Development of a Nanostructured Lipid Carrier Formulation by Hot-Melt Extrusion Technology. Bhagurkar AM; Repka MA; Murthy SN J Pharm Sci; 2017 Apr; 106(4):1085-1091. PubMed ID: 28040458 [TBL] [Abstract][Full Text] [Related]
53. Development and Evaluation of Astaxanthin as Nanostructure Lipid Carriers in Topical Delivery. Geng Q; Zhao Y; Wang L; Xu L; Chen X; Han J AAPS PharmSciTech; 2020 Nov; 21(8):318. PubMed ID: 33175290 [TBL] [Abstract][Full Text] [Related]
54. The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers. Santos GA; Angelo T; Andrade LM; Silva SMM; Magalhães PO; Cunha-Filho M; Gelfuso GM; Taveira SF; Gratieri T Colloids Surf B Biointerfaces; 2018 Oct; 170():341-346. PubMed ID: 29940500 [TBL] [Abstract][Full Text] [Related]
55. Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone. Li B; Ge ZQ AAPS PharmSciTech; 2012 Mar; 13(1):276-83. PubMed ID: 22234598 [TBL] [Abstract][Full Text] [Related]
56. Improved skin delivery of voriconazole with a nanostructured lipid carrier-based hydrogel formulation. Song SH; Lee KM; Kang JB; Lee SG; Kang MJ; Choi YW Chem Pharm Bull (Tokyo); 2014; 62(8):793-8. PubMed ID: 25087631 [TBL] [Abstract][Full Text] [Related]
57. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
58. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam. Dasgupta S; Ray S; Dey S; Pal P; Mazumder B Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909 [TBL] [Abstract][Full Text] [Related]
59. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design. Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618 [TBL] [Abstract][Full Text] [Related]
60. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]